卡地纳健康(CAH)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

CAH 卡地纳健康

盘前交易 08-10 08:16:38 EDT

236.40

-1.26

-0.53%

盘前235.00

-1.40-0.59%

08:02 EDT

最高239.85	最低236.30	成交量155.11万
今开237.23	昨收237.66	日振幅1.49%
总市值556.29亿	流通市值552.30亿	总股本2.35亿
成交额3.69亿	换手率0.66%	流通股本2.34亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"CAH","market":"US","secType":"STK","nameCN":"卡地纳健康","latestPrice":236.4,"timestamp":1786132800000,"preClose":237.66,"halted":0,"volume":1551067,"hourTrading":{"tag":"盘前","latestPrice":235,"preClose":236.4,"latestTime":"08:02 EDT","volume":568,"amount":134457.23832,"timestamp":1786363379405,"change":-1.4,"changeRate":-0.005922,"amplitude":0.066525},"delay":0,"changeRate":-0.005301691492047424,"floatShares":233629753,"shares":235316016,"eps":6.53725,"marketStatus":"盘前交易","change":-1.26,"latestTime":"08-10 08:16:38 EDT","open":237.23,"high":239.85,"low":236.3,"amount":369064154.73137003,"amplitude":0.014937,"askPrice":240.13,"askSize":8,"bidPrice":232.59,"bidSize":2,"shortable":3,"etf":0,"ttmEps":6.53725,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1786368600000},"marketStatusCode":1,"adr":0,"adrRate":0,"listingDate":428558400000,"exchange":"NYSE","adjPreClose":236.4,"dividendRate":0.008641,"preHourTrading":{"tag":"盘前","latestPrice":235,"preClose":236.4,"latestTime":"08:02 EDT","volume":568,"amount":134457.23832,"timestamp":1786363379405,"change":-1.4,"changeRate":-0.005922,"amplitude":0.066525},"postHourTrading":{"tag":"盘后","latestPrice":236.4,"preClose":236.4,"latestTime":"19:34 EDT","volume":38170,"amount":9023417.68,"timestamp":1786145649256,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.7141594903973525,"impliedVol":0.3719,"impliedVolPercentile":0.824},"requestUrl":"/m/hq/s/CAH/wiki","defaultTab":"wiki","newsList":[{"id":"1168179405","title":"卡地纳健康：交易预计在完成后的首12个月内对调整后每股收益产生增厚效应","url":"https://stock-news.laohu8.com/highlight/detail?id=1168179405","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1168179405?lang=zh_cn&edition=full","pubTime":"2026-07-21 04:48","pubTimestamp":1784580490,"startTime":"0","endTime":"0","summary":"卡地纳健康披露，相关交易预计将在完成后的首个12个月内，对公司的非公认会计准则每股收益产生增厚作用。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0211328371.USD","BK4588","LU0128525689.USD","BK4175","LU0310800965.SGD","LU1880398471.USD","LU0889566641.SGD","LU0162691827.USD","LU0154236417.USD","SG9999001440.SGD","LU1267930813.SGD","LU0052756011.USD","LU1983299246.USD","LU0310799852.SGD","LU0211327993.USD","LU0792757196.USD","CAH","LU0006061336.USD","LU0072461881.USD","AHCO","LU1571399168.USD","BK4585","LU1880398554.USD","LU1267930227.SGD","LU1267930490.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1131849406","title":"异动解读 | 成本压力与增长放缓，卡地纳健康盘中大跌5.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=1131849406","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1131849406?lang=zh_cn&edition=full","pubTime":"2026-04-30 21:39","pubTimestamp":1777556343,"startTime":"0","endTime":"0","summary":"卡地纳健康（CAH）今日盘中股价大跌5.33%，市场表现引人关注。消息面上，公司高管在电话会议中透露，与《通胀削减法案》相关的批发采购成本调整对公司整体增长率产生了下行压力。同时，尽管GLP-1类药物销量增长率仍保持在30%以上，但增长势头已较此前明显放缓。这些因素共同影响了市场对该公司短期增长前景的预期，可能是导致股价承压下跌的主要原因。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["CAH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143971235","title":"卡地纳健康高管称《通胀削减法案》相关批发采购成本变动拖累整体增长率 - 电话会议","url":"https://stock-news.laohu8.com/highlight/detail?id=1143971235","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1143971235?lang=zh_cn&edition=full","pubTime":"2026-04-30 21:24","pubTimestamp":1777555477,"startTime":"0","endTime":"0","summary":"卡地纳健康高管在电话会议中透露，与《通胀削减法案》相关的批发采购成本调整对公司整体增长率产生了下行压力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0792757196.USD","BK4585","LU1983299246.USD","BK4588","LU1880398471.USD","LU1880398554.USD","LU0006061336.USD","LU0052756011.USD","LU0889566641.SGD","LU0128525689.USD","LU1267930490.SGD","LU1267930227.SGD","LU1267930813.SGD","BK4175","LU0072461881.USD","SG9999001440.SGD","LU0211328371.USD","LU0211327993.USD","LU0310799852.SGD","LU0162691827.USD","CAH","LU1571399168.USD","LU0310800965.SGD","LU0154236417.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1135092418","title":"卡地纳健康高管：GLP-1药物销量增速仍超30%，但较此前有所放缓","url":"https://stock-news.laohu8.com/highlight/detail?id=1135092418","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1135092418?lang=zh_cn&edition=full","pubTime":"2026-04-30 21:21","pubTimestamp":1777555302,"startTime":"0","endTime":"0","summary":"卡地纳健康公司高管在电话会议中透露，尽管GLP-1类药物销量增长率仍保持在30%以上，但增长势头已较此前明显放缓。\n该公司指出，这类用于糖尿病和肥胖症治疗的药物持续保持强劲需求，但市场扩张速度正在逐步回归理性区间。目前GLP-1药物业务仍是卡地纳健康重要的增长驱动力之一。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0889566641.SGD","LU1983299246.USD","LU1571399168.USD","BK4175","LU1267930227.SGD","LU1880398554.USD","LU0006061336.USD","LU0072461881.USD","LU0211328371.USD","LU0211327993.USD","LU0162691827.USD","LU1267930813.SGD","LU0792757196.USD","LU0052756011.USD","LU0310800965.SGD","BK4585","LU1880398471.USD","CAH","SG9999001440.SGD","LU0310799852.SGD","LU0128525689.USD","LU1267930490.SGD","LU0154236417.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1136207744","title":"卡地纳健康扩大锕-225产能，以满足新型癌症疗法日益增长的需求","url":"https://stock-news.laohu8.com/highlight/detail?id=1136207744","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1136207744?lang=zh_cn&edition=full","pubTime":"2026-04-01 19:01","pubTimestamp":1775041305,"startTime":"0","endTime":"0","summary":"为应对市场对创新癌症治疗手段不断攀升的需求，卡地纳健康已宣布扩大其放射性同位素锕-225的生产规模。此次产能提升旨在保障这种关键治疗材料的稳定供应，从而支持靶向放射性药物等前沿疗法的研发与应用。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1880398554.USD","LU1267930813.SGD","LU0154236417.USD","LU0162691827.USD","SG9999001440.SGD","LU0211328371.USD","LU0310800965.SGD","BK4175","LU0072461881.USD","BK4588","LU1880398471.USD","LU0792757196.USD","LU0310799852.SGD","LU0211327993.USD","LU1267930227.SGD","LU0006061336.USD","LU1267930490.SGD","CAH","BK4585","LU0889566641.SGD","LU1571399168.USD","LU0052756011.USD","LU0128525689.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1175526367","title":"美股波动预期加剧，这些稳健的高股息股可为投资组合保驾护航","url":"https://stock-news.laohu8.com/highlight/detail?id=1175526367","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1175526367?lang=zh_cn&edition=full","pubTime":"2025-02-20 15:12","pubTimestamp":1740035549,"startTime":"0","endTime":"0","summary":"随着2025年美股市场波动预期加剧，投资者或可考虑增持高股息股票以平滑投资风险。在市场波动时期，稳定派息股票常被视为“压舱石”，其股息收入能够在股价下跌时提供缓冲。其中，“股息贵族”尤其值得关注，这些公司已连续至少25年提高股息。此外，这些股票的股息率均高于标准普尔500指数1.24%的水平。该公司本月宣布计划拆分生命科学和诊断业务。今年以来该股股价微跌。年内股价下跌超6%，但目标价隐含18%上涨空间。","market":"us","thumbnail":"https://community-static.tradeup.com/news/daf8c6efec812c4e4d5211ffbcf205b8","type":0,"news_type":0,"thumbnails":["https://community-static.tradeup.com/news/daf8c6efec812c4e4d5211ffbcf205b8"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"美股波动预期加剧，这些稳健的高股息股可为投资组合保驾护航","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CAH","NEE","EMR","BDX","FRT","CVX","PG"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2509410816","title":"Gangtise投研日报 | 2025-02-05","url":"https://stock-news.laohu8.com/highlight/detail?id=2509410816","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509410816?lang=zh_cn&edition=full","pubTime":"2025-02-05 06:30","pubTimestamp":1738708200,"startTime":"0","endTime":"0","summary":"　　1．深圳机场预计2024年归属于上市公司股东的净利润为3.998亿元至4.438亿元，同比增长0.78%至11.88%。扣除非经常性损益后，预计净利润为2.961亿元至3.561亿元，同比增长289.24%至327.59%。基本每股收益预计为0.195元/股至0.2164元/股。经营态势良好，营业收入增幅远大于成本费用增幅。　　5． United Microelectronics Corporation 2024年第四季度业绩电话会：2024年第四季度，联电合并营收为504亿新台币，毛利率30.4%，股东应占净收入85亿新台币，每股收益4.682美元。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2025-02-05/doc-ineiktkp5483790.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4168","BK4585","IE00BJJMRZ35.SGD","IE00B4R5TH58.HKD","BK4588","BK4578","IE00BJT1NW94.SGD","LU0310799852.SGD","IE00BFTCPJ56.SGD","LU1571399168.USD","NVS","LU0211327993.USD","BK4007","LU0211331839.USD","LU0889566641.SGD","LINRF","LU1880398554.USD","BK4554","IE0002141913.USD","BK4141","LU0162691827.USD","BK4526","LU0211328371.USD","UMC","LU1880398471.USD","BK4231","BK4532","BK4175","LU0792757196.USD","LU0310800965.SGD","LU1267930227.SGD","IE0009355771.USD","BK4017","BK4080","LU1267930813.SGD","SG9999001440.SGD","LU1267930490.SGD","LU0154236417.USD","CAH","ROIC","LU0072461881.USD","LU0128525689.USD","IE00B2B36J28.USD","LU0006061336.USD","NESRF","LU0052756011.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2508468929","title":"小摩：维持Cardinal Health(CAH.US)评级，由中性调整至中性评级, 目标价由142.00美元调整至145.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2508468929","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2508468929?lang=zh_cn&edition=full","pubTime":"2025-02-04 23:13","pubTimestamp":1738681987,"startTime":"0","endTime":"0","summary":"小摩：维持Cardinal Health(CAH.US)评级，由中性调整至中性评级, 目标价由142.00美元调整至145.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/04231347949905.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["CAH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2507644448","title":"Cardinal Health(CAH.US)：2025年Q2财报实现营收552.64亿美元，前值为574.45亿美元，预期值为549.7亿美元；每股收益为1.93美元，前值为1.89美元，预期值为1.76美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2507644448","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2507644448?lang=zh_cn&edition=full","pubTime":"2025-01-30 19:54","pubTimestamp":1738238063,"startTime":"0","endTime":"0","summary":"Cardinal Health(CAH.US)：2025年Q2财报实现营收552.64亿美元，前值为574.45亿美元，预期值为549.7亿美元；每股收益为1.93美元，前值为1.89美元，预期值为1.76美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/01/30195447908896.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["CAH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1192403175","title":"Cardinal Health 2025年第二季度调整后每股收益$1.93击败$1.76预期，销售额$553亿击败$549.15亿预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1192403175","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1192403175?lang=zh_cn&edition=full","pubTime":"2025-01-30 19:52","pubTimestamp":1738237978,"startTime":"0","endTime":"0","summary":"Cardinal Health 2025年第二季度调整后每股收益$1.93击败$1.76预期，销售额$553亿击败$549.15亿预期以上内容来自Benzinga Earnings专栏，原文如下：Cardinal Health Q2 2025 Adj. EPS $1.93 Beats $1.76 Estimate, Sales $55.3B Beat $54.915B Estimate","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Cardinal Health 2025年第二季度调整后每股收益$1.93击败$1.76预期，销售额$553亿击败$549.15亿预期","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CAH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2507042684","title":"富国银行：维持Cardinal Health(CAH.US)评级，由持股观望调整至持股观望评级, 目标价由127.00美元调整至135.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2507042684","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2507042684?lang=zh_cn&edition=full","pubTime":"2025-01-29 19:42","pubTimestamp":1738150962,"startTime":"0","endTime":"0","summary":"富国银行：维持Cardinal Health(CAH.US)评级，由持股观望调整至持股观望评级, 目标价由127.00美元调整至135.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/01/29194247896901.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["CAH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2502381667","title":"花旗：维持Cardinal Health(CAH.US)评级，由中性调整至中性评级, 目标价由120.00美元调整至129.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2502381667","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2502381667?lang=zh_cn&edition=full","pubTime":"2025-01-11 03:11","pubTimestamp":1736536303,"startTime":"0","endTime":"0","summary":"花旗：维持Cardinal Health(CAH.US)评级，由中性调整至中性评级, 目标价由120.00美元调整至129.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/01/11031147365003.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["CAH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2502062017","title":"TD Cowen：上调Cardinal Health(CAH.US)评级，由持有调整至买入评级, 目标价由130.00美元调整至144.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2502062017","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2502062017?lang=zh_cn&edition=full","pubTime":"2025-01-09 02:03","pubTimestamp":1736359381,"startTime":"0","endTime":"0","summary":"TD Cowen：上调Cardinal Health(CAH.US)评级，由持有调整至买入评级, 目标价由130.00美元调整至144.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/01/09020347279995.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["TD","CAH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2501208068","title":"Evercore ISI Group：上调Cardinal Health评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2501208068","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2501208068?lang=zh_cn&edition=full","pubTime":"2025-01-07 19:36","pubTimestamp":1736249812,"startTime":"0","endTime":"0","summary":"evercore ISI Group：上调Cardinal Health(CAH.US)评级，由大市同步调整至优于大市评级,目标价由140.00美元调整至140.00美元。卡地纳健康(CAH.US)公司简介：卡地纳健康集团是一家医疗保健服务和产品公司，从事为医院、医疗保健系统、药房、门诊手术中心、临床实验室和医生办公室提供定制解决方案。它还提供医疗产品和药品以及具有成本效益的解决方案，以提高供应链效率。该公司通过制药和医疗部门运营。制药部门分销品牌和仿制药，专业药品和非处方医疗保健和消费品。医疗部门生产、采购和分销卡地纳健康品牌的医疗、外科和实验室产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250107194539a218c113&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250107194539a218c113&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["EVR","CAH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2492942352","title":"【券商聚焦】摩根士丹利：北美医疗保健服务行业MA预期改善 个股目标价及评级各有调整","url":"https://stock-news.laohu8.com/highlight/detail?id=2492942352","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2492942352?lang=zh_cn&edition=full","pubTime":"2024-12-18 10:37","pubTimestamp":1734489456,"startTime":"0","endTime":"0","summary":"摩根士丹利对这一领域的评级为“与市场一致”。此外，对于医疗保健技术和提供商，摩根士丹利建议保持选择性，因为需求和政策不确定性混合。对于行业中一些公司，摩根士丹利给出了以下评级和预期：对于Elevance Health Inc，摩根士丹利将其评级从“跑赢大市”下调至“与大市同步”，目标价从551美元降至388美元。对于Accolade Inc，目标价从6美元降至5美元，维持“与大市同步”评级。对于Cardinal Health Inc，目标价从127美元升至136美元，维持“跑赢大市”评级。","market":"nz","thumbnail":"https://static.szfiu.com/news/20210810/OTE1MjMxNjI4NTkwNjg5MDI0.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/OTE1MjMxNjI4NTkwNjg5MDI0.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"283371","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DGX","GDRX","LFST","HCA","ELV","HCSG","AMWL","ACCD","CAH","MA","VEEV","HUM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2482221364","title":"卡地纳健康2024财年第三财季实现净利润4.16亿美元，同比增加8220.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2482221364","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2482221364?lang=zh_cn&edition=full","pubTime":"2024-11-10 00:01","pubTimestamp":1731168107,"startTime":"0","endTime":"0","summary":"11月10日，卡地纳健康公布财报，公告显示公司2024财年第三财季净利润为4.16亿美元，同比增加8220.00%；其中营业收入为522.77亿美元，同比减少4.54%，每股基本收益为1.71美元。从资产负债表来看，卡地纳健康总负债463.35亿美元，其中短期债务9.40亿美元，资产负债比为0.93，流动比率为0.95。机构评级：截至2024年11月10日，当前有15家机构对卡地纳健康目标价做出预测，其中目标均价为126.40美元，其中最低目标价为101.00美元，最高目标价为145.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241110000207a22785ef&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241110000207a22785ef&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CAH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1146173123","title":"异动解读 | 特药销售强劲 卡地纳健康上调年度利润预期引发股价大涨","url":"https://stock-news.laohu8.com/highlight/detail?id=1146173123","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1146173123?lang=zh_cn&edition=full","pubTime":"2024-11-02 06:14","pubTimestamp":1730499286,"startTime":"0","endTime":"0","summary":"11月1日,全美领先的药品分销商卡地纳健康公司盘中股价大涨9.53%,报114.42美元,引发了市场的广泛关注。这一利好预期主要源于公司制药业务的强劲表现。与此同时,该公司此前以11.2亿美元收购了社区癌症中心运营商Integrated Oncology Network,进一步加大了在特药和复杂疾病治疗药物领域的布局。分析人士认为,这一举措将增强公司在高利润细分市场的竞争力,提升其长期增长潜力,从而支撑当日股价的大涨行情。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["CAH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1102196442","title":"异动解读 | 卡地纳健康上调年度利润预期 特药销售强劲引发股价大涨","url":"https://stock-news.laohu8.com/highlight/detail?id=1102196442","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1102196442?lang=zh_cn&edition=full","pubTime":"2024-11-01 21:38","pubTimestamp":1730468305,"startTime":"0","endTime":"0","summary":"11月1日,药品分销商卡地纳健康公司盘中股价大涨6.91%,报111.04美元,引发市场广泛关注。公司上调了2025财年每股收益预期,从之前的7.55-7.70美元上调至7.75-7.90美元,超出分析师预期。数据显示,卡地纳健康第一季度每股收益为1.88美元,高于分析师平均预期的1.62美元。卡地纳健康此前以11.2亿美元收购了社区癌症中心运营商Integrated Oncology Network,进军癌症治疗领域。分析人士表示,投资者对公司在特药领域的增长前景较为乐观,支撑了当日股价的大涨。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["CAH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2480889821","title":"卡地纳健康盘中异动 早盘急速拉升5.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2480889821","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2480889821?lang=zh_cn&edition=full","pubTime":"2024-11-01 21:32","pubTimestamp":1730467962,"startTime":"0","endTime":"0","summary":"北京时间2024年11月01日21时32分，卡地纳健康股票出现波动，股价大幅拉升5.44%。卡地纳健康股票所在的医疗销售行业中，整体涨幅为2.23%。其相关个股中，卡地纳健康、欧麦斯-麦能医疗、Cencora, Inc.涨幅较大，卡地纳健康、帕特森、Cencora, Inc.较为活跃，换手率分别为0.10%、0.04%、0.04%，振幅较大的相关个股有卡地纳健康、Cencora, Inc.、麦克森，振幅分别为2.62%、1.85%、1.45%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110121324295bdab17&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110121324295bdab17&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0310799852.SGD","LU1880398471.USD","LU1267930813.SGD","BK4588","CAH","LU0211328371.USD","BK4585","LU0310800965.SGD","LU0072461881.USD","LU0128525689.USD","LU0006061336.USD","LU0889566641.SGD","SG9999001440.SGD","BK4175","LU0162691827.USD","LU0792757196.USD","LU1267930490.SGD","LU1880398554.USD","LU0211327993.USD","LU0052756011.USD","LU1267930227.SGD","LU1571399168.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1161215385","title":"异动解读 | 卡地纳健康上调年度利润预期 股价大涨5.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=1161215385","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1161215385?lang=zh_cn&edition=full","pubTime":"2024-11-01 21:31","pubTimestamp":1730467882,"startTime":"0","endTime":"0","summary":"11月1日,药品分销商卡地纳健康公司盘前股价大涨5.52%,报111.04美元,引发市场广泛关注。卡地纳健康当日上调了2025财年每股收益预期,将之前的 7.55-7.70美元区间上调至7.75-7.90美元。该公司预计,制药和特殊解决方案部门的利润将增长4%至6%,而之前的预测为增长1%至3%。专家指出,随着公司加大在特药领域的投资,其在复杂疾病治疗药物分销方面的竞争力有望进一步提高,支撑业绩持续向好。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["CAH"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cardinalhealth.com","stockEarnings":[{"period":"1week","weight":0.0277},{"period":"1month","weight":-0.0032},{"period":"3month","weight":0.2872},{"period":"6month","weight":0.0445},{"period":"1year","weight":0.541},{"period":"ytd","weight":0.1504}],"compareEarnings":[{"period":"1week","weight":0.0351},{"period":"1month","weight":0.0374},{"period":"3month","weight":0.0483},{"period":"6month","weight":0.1197},{"period":"1year","weight":0.223},{"period":"ytd","weight":0.1339}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"卡地纳健康集团是一家成立于1979年的俄亥俄州公司，是一家全球整合的医疗服务和产品公司，为医院，医疗系统，药房，门诊手术中心，临床实验室，医师办公室和家庭患者提供定制化解决方案。该公司提供药品和医疗产品以及具有成本效益的解决方案，以提高供应链效率。该公司将患者，提供者，付款人，药剂师和制造商联系在一起，以实现综合护理协调和更好的患者管理。该公司管理其业务并报告其财务业绩，分为两个部分：制药和医疗。","yearOnYearQuotes":[{"month":1,"riseRate":0.72093,"avgChangeRate":0.0383},{"month":2,"riseRate":0.697674,"avgChangeRate":0.015847},{"month":3,"riseRate":0.534884,"avgChangeRate":0.010705},{"month":4,"riseRate":0.395349,"avgChangeRate":-0.006028},{"month":5,"riseRate":0.627907,"avgChangeRate":0.020617},{"month":6,"riseRate":0.55814,"avgChangeRate":0.021029},{"month":7,"riseRate":0.581395,"avgChangeRate":0.005465},{"month":8,"riseRate":0.52381,"avgChangeRate":0.002851},{"month":9,"riseRate":0.511628,"avgChangeRate":0.009806},{"month":10,"riseRate":0.488372,"avgChangeRate":-0.017903},{"month":11,"riseRate":0.697674,"avgChangeRate":0.03615},{"month":12,"riseRate":0.534884,"avgChangeRate":0.009388}],"exchange":"NYSE","name":"卡地纳健康","nameEN":"Cardinal Health"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"卡地纳健康(CAH)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供卡地纳健康(CAH)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"卡地纳健康,CAH,卡地纳健康股票,卡地纳健康股票老虎,卡地纳健康股票老虎国际,卡地纳健康行情,卡地纳健康股票行情,卡地纳健康股价,卡地纳健康股市,卡地纳健康股票价格,卡地纳健康股票交易,卡地纳健康股票购买,卡地纳健康股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"卡地纳健康(CAH)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供卡地纳健康(CAH)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}